Hardus Viljoen

Person

Born

1989-03-06

via Open Library + Wikidata

Recent publications · Crossref

5 total works indexed

1. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

   · 2021 · cited 1,172x

2. Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

   · 2021 · cited 999x

3. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

   · 2017 · cited 939x

4. Are we ready for SDN? Implementation challenges for software-defined networks

   · 2013 · cited 786x

5. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

   · 2018 · cited 670x